Companies · Other Health Care

Pico-Tesla Magnetic Therapies, LLC.

CLEARWATER · Other Health Care

Diligence memoA one-page analyst read on Pico-Tesla Magnetic Therapies, LLC. — recommendation, valuation, rhythm, risks.
$49.0M
Total raised · real
20
Rounds
0.5×
Latest step-up
Top 9%
Sector rank · raised
Recurring offerings
Latest stage · inferred · Fri Feb 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time)

Pico-Tesla Magnetic Therapies, LLC. has raised $49M over 20 rounds; too few niche peers to rank its valuation yet.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Program ended
  • Last raise 16.4 yr ago; this sector typically re-raises about every 14 months.
  • For a recurring offering issuer, long silence usually means the offering program is inactive or ended; it is not proof the legal entity is defunct.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Recurring offering issuerhigh confidence

Pico-Tesla Magnetic Therapies, LLC. behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Program-like
Frequent filings and follow-ons read more like a securities offering program than discrete startup rounds.
Lifecycle
16.4 yr record
Peak capital year was 2010 with $49.0M across 20 filings.
Market position
ahead of 92% of Other Health Care peers
Capital scale is ahead of 92% of Other Health Care peers; modeled value is above 77% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Lower applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • 20 dated financing filings, averaging about 0 months apart.
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2010: $49.0M across 20 filings.
  • Largest single filing was $3.7M on 2010-02-12.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Pico-Tesla Magnetic Therapies, LLC. is one of 5377 Other Health Care companies tracked from CLEARWATER. By capital raised it ranks among the largest (ahead of 92% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by year

This issuer has a dense recurring filing history, so the chart groups filings by year. Solid bars are annual reported capital reported; hatched bars show the latest modeled value est. observed in that year. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Annual capital raised · realLatest value in year · estCumulative funded · real

Dense history compressed: 20 filings shown as 1 yearly buckets. Hover a bucket for filing count, annual capital, and latest modeled value.

$0$13M$25M$38M$50M2010: 20 filings Raised $49M total (real) Latest modeled valuation $12M (est)201020 filings

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps

This looks like a recurring offering series, so a VC stage ladder would be misleading. Showing the filed offering sequence instead.

Initial offering$3.7M · 2010
Follow-on offering$3.6M · 2010
Follow-on offering$3.6M · 2010
Follow-on offering$3.5M · 2010
Follow-on offering$3.5M · 2010
Follow-on offering$3.3M · 2010
Follow-on offering$3.1M · 2010
Follow-on offering$3.0M · 2010
Follow-on offering$3.0M · 2010
Follow-on offering$2.9M · 2010
Follow-on offering$2.7M · 2010
Follow-on offering$2.5M · 2010
Follow-on offering$2.2M · 2010
Follow-on offering$1.8M · 2010
Follow-on offering$1.7M · 2010
Follow-on offering$1.6M · 2010
Follow-on offering$1.1M · 2010
Follow-on offering$1.0M · 2010
Follow-on offering$850K · 2010
Follow-on offering$400K · 2010
Modeled valuation trajectory
$90.8M
Base estimate est.
$3.1M
Conservative case
$712.7M
Upside case
$18.3M
Modeled post-money

This issuer files recurring offerings, so the model treats stage labels as a loose sizing heuristic, not a clean VC ladder. The estimate anchors on reported filing amounts and dates, then applies benchmark dilution, survival, and markup assumptions. Directional, not a quoted figure.

Seed · modeled $90.8M · 2010-02-122010Seed · modeled $89.3M · 2010-02-12Seed · modeled $88.1M · 2010-02-12Seed · modeled $87.7M · 2010-02-12Seed · modeled $86.2M · 2010-02-12Seed · modeled $82.2M · 2010-02-12Seed · modeled $78.1M · 2010-02-12Seed · modeled $74.4M · 2010-02-12Seed · modeled $73.1M · 2010-02-12Seed · modeled $70.6M · 2010-02-12Seed · modeled $66.9M · 2010-02-12Seed · modeled $63.2M · 2010-02-12Seed · modeled $55.3M · 2010-02-12Seed · modeled $45.4M · 2010-02-12Seed · modeled $42.9M · 2010-02-12Seed · modeled $38.9M · 2010-02-12Seed · modeled $26.0M · 2010-02-12Pre-Seed · modeled $30.8M · 2010-02-12Pre-Seed · modeled $26.2M · 2010-02-12Pre-Seed · modeled $12.3M · 2010-02-122010
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.54×/yr
Annual markup
2.01×/yr upside case
6.0 yr
Elapsed time used
16.4 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
0 mo
Avg between rounds
Capital velocity
16.4 yr
On record since
2010
First round
20
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 20× above median
This company$49.0M
Sector median$2.4M
Modeled value — vs sector median (estimate, all stages) 4.1× above median
This company$90.8M
Sector median$22.1M

Raised more than 92% of sector peers (real $). Modeled value above 77% of peers (estimate).

Full financing history

This issuer files too frequently for VC stage labels to be meaningful, so rows are shown as initial/follow-on offerings est. instead of Pre-Seed/Seed/Series buckets.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Initial offering$3.7M2010-02-12$18.3M$90.8M90%
Follow-on offering$3.6M2010-02-12$18.0M$89.3M90%
Follow-on offering$3.6M2010-02-12$17.8M$88.1M90%
Follow-on offering$3.5M2010-02-12$17.7M$87.7M90%
Follow-on offering$3.5M2010-02-12$17.4M$86.2M90%
Follow-on offering$3.3M2010-02-12$16.6M$82.2M90%
Follow-on offering$3.1M2010-02-12$15.8M$78.1M90%
Follow-on offering$3.0M2010-02-12$15.0M$74.4M90%
Follow-on offering$3.0M2010-02-12$14.8M$73.1M90%
Follow-on offering$2.9M2010-02-12$14.3M$70.6M90%
Follow-on offering$2.7M2010-02-12$13.5M$66.9M90%
Follow-on offering$2.5M2010-02-12$12.8M$63.2M90%
Follow-on offering$2.2M2010-02-12$11.2M$55.3M90%
Follow-on offering$1.8M2010-02-12$9.2M$45.4M90%
Follow-on offering$1.7M2010-02-12$8.7M$42.9M90%
Follow-on offering$1.6M2010-02-12$7.8M$38.9M90%
Follow-on offering$1.1M2010-02-12$5.3M$26.0M90%
Follow-on offering$1.0M2010-02-12$5.6M$30.8M90%
Follow-on offering$850K2010-02-12$4.7M$26.2M90%
Follow-on offering$400K2010-02-12$2.2M$12.3M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Initial offering$3.7M2010-02-12
    • First recorded raise — entered as Initial offering.
  2. Follow-on offering$3.6M2010-02-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  3. Follow-on offering$3.6M2010-02-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  4. Follow-on offering$3.5M2010-02-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  5. Follow-on offering$3.5M2010-02-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  6. Follow-on offering$3.3M2010-02-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  7. Follow-on offering$3.1M2010-02-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  8. Follow-on offering$3.0M2010-02-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  9. Follow-on offering$3.0M2010-02-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  10. Follow-on offering$2.9M2010-02-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  11. Follow-on offering$2.7M2010-02-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  12. Follow-on offering$2.5M2010-02-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  13. Follow-on offering$2.2M2010-02-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  14. Follow-on offering$1.8M2010-02-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  15. Follow-on offering$1.7M2010-02-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  16. Follow-on offering$1.6M2010-02-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  17. Follow-on offering$1.1M2010-02-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.5× smaller than the prior — bridge or down round.
  18. Follow-on offering$1.0M2010-02-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  19. Follow-on offering$850K2010-02-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  20. Follow-on offering$400K2010-02-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.1× smaller than the prior — bridge or down round.
Intelligence
Modeled next raise
$400K
Modeled next size est.range $400K$640K
0.5×
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Allen S Braswell, Jr.2010-02
James A Doran2010-02
Registry & provenance

Pico-Tesla Magnetic Therapies, LLC. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1483064
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Hotspur Technologies IncOther Health CareSeed$20.6M$91.2Msame sector · same stage
AVAVA, Inc.Other Health CareSeries B$48.8M$78.0Msame sector
Novasys Medical IncOther Health CareSeries C$49.4M$90.0Msame sector
Sapheon, Inc.Other Health CareSeed$15.9M$88.2Msame sector · same stage
Ensodata, Inc.Other Health CareSeries B$50.7M$97.5Msame sector
Zyga Technology, Inc.Other Health CareSeries A$46.8M$100.9Msame sector
Cardionomic, Inc.Other Health CareSeries B$51.7M$76.3Msame sector
Stat Health Services Inc.Other Health CareSeed$12.9M$86.7Msame sector · same stage
Frequently asked
How much funding has Pico-Tesla Magnetic Therapies, LLC. raised?
Pico-Tesla Magnetic Therapies, LLC. has raised approximately $49.0M in disclosed capital across 20 recorded financing rounds, aggregated from public filings.
What is Pico-Tesla Magnetic Therapies, LLC.'s estimated valuation?
Provath's modeled valuation for Pico-Tesla Magnetic Therapies, LLC. is approximately $90.8M (modeled range $3.1M–$712.7M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Pico-Tesla Magnetic Therapies, LLC. at?
Pico-Tesla Magnetic Therapies, LLC. shows a recurring offering pattern rather than a clean VC stage progression. Its most recent recorded round closed around Fri Feb 12.
What does Pico-Tesla Magnetic Therapies, LLC. do and where is it based?
Pico-Tesla Magnetic Therapies, LLC. operates in the Other Health Care sector, based in CLEARWATER.
Explore related

See where Pico-Tesla Magnetic Therapies, LLC. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Pico-Tesla Magnetic Therapies, LLC., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.